BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31152021)

  • 41. [Association between interleukin-18 gene polymorphisms and hepatocellular carcinoma caused by hepatitis B virus].
    Zhang QX; Yao YQ; Li SL; Long Q
    Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):352-7. PubMed ID: 27470888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of PTPRD rs2279776 gene and interaction with hepatitis B virus mutations on the risk of hepatocellular carcinoma].
    Deng Y; Zhang Q; Zhang YW; Han X; Cao GW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Dec; 34(12):1228-32. PubMed ID: 24518026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.
    Sriprapun M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Tangkijvanich P
    Asian Pac J Cancer Prev; 2016; 17(4):2019-25. PubMed ID: 27221889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
    Yang Z; Zhuang L; Lu Y; Xu Q; Tang B; Chen X
    Oncotarget; 2016 Mar; 7(11):12525-36. PubMed ID: 26848866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B.
    Hoan NX; Van Tong H; Giang DP; Cuong BK; Toan NL; Wedemeyer H; Bock CT; Kremsner PG; Song LH; Velavan TP
    Oncotarget; 2017 Mar; 8(10):17127-17139. PubMed ID: 28179578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant.
    Halgand B; Desterke C; Rivière L; Fallot G; Sebagh M; Calderaro J; Bioulac-Sage P; Neuveut C; Buendia MA; Samuel D; Féray C
    Hepatology; 2018 Jan; 67(1):86-96. PubMed ID: 28802063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression quantitative trait loci for TNFRSF10 influence both HBV infection and hepatocellular carcinoma development.
    Wen J; Song C; Liu J; Chen J; Zhai X; Hu Z
    J Med Virol; 2016 Mar; 88(3):474-80. PubMed ID: 26297860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.
    Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L
    Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression.
    Wang D; Li X; Li J; Lu Y; Zhao S; Tang X; Chen X; Li J; Zheng Y; Li S; Sun R; Yan M; Yu D; Cao G; Yang Y
    Gut; 2019 Oct; 68(10):1846-1857. PubMed ID: 31154396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toll-like receptor 9 polymorphisms and Hepatitis B virus clearance in Moroccan chronic carriers.
    Chihab H; Zaidane I; Elhabazi A; Jadid FZ; El Fihri R; Elmessaoudi-Idrissi M; Chair M; Badre W; Tahiri M; Pineau P; Chemin I; Ezzikouri S; Benjelloun S
    Gene; 2019 Mar; 687():212-218. PubMed ID: 30453064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hepatitis B virus (HBV) mutation in enhancer I (HBV Enh I)/X-promoter and the relationship between chronic HBV-related disease spectrum].
    Deng HH; Guan YJ; Lei CL; Xu M; Hu FY; Cheng J; Li YP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):25-7. PubMed ID: 22919746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
    Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F
    Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
    Tharayil VS; Roberts LR
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients.
    Al-Qahtani AA; Al-Anazi M; Abdo AA; Sanai FM; Al-Hamoudi W; Alswat KA; Al-Ashgar HI; Khalaf N; Viswan N; Al-Ahdal MN
    Exp Mol Pathol; 2013 Dec; 95(3):255-8. PubMed ID: 23994040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
    Chou YC; Yu MW; Wu CF; Yang SY; Lin CL; Liu CJ; Shih WL; Chen PJ; Liaw YF; Chen CJ
    Gut; 2008 Jan; 57(1):91-7. PubMed ID: 17502344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long non-coding RNA HULC activates HBV by modulating HBx/STAT3/miR-539/APOBEC3B signaling in HBV-related hepatocellular carcinoma.
    Liu Y; Feng J; Sun M; Yang G; Yuan H; Wang Y; Bu Y; Zhao M; Zhang S; Zhang X
    Cancer Lett; 2019 Jul; 454():158-170. PubMed ID: 30981758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PIN1 genetic polymorphisms and the susceptibility of HBV-related hepatocellular carcinoma in a Guangxi population.
    Huang L; Mo Z; Lao X; Zhang X; Liu Y; Sui J; Qin X; Li S
    Tumour Biol; 2016 May; 37(5):6599-606. PubMed ID: 26643892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma.
    Zhang T; Cai J; Chang J; Yu D; Wu C; Yan T; Zhai K; Bi X; Zhao H; Xu J; Tan W; Qu C; Lin D
    Hum Mol Genet; 2013 Mar; 22(6):1262-9. PubMed ID: 23213177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deep sequencing of HBV pre-S region reveals high heterogeneity of HBV genotypes and associations of word pattern frequencies with HCC.
    Bai X; Jia JA; Fang M; Chen S; Liang X; Zhu S; Zhang S; Feng J; Sun F; Gao C
    PLoS Genet; 2018 Feb; 14(2):e1007206. PubMed ID: 29474353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.
    Kim JK; Chang HY; Lee JM; Baatarkhuu O; Yoon YJ; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
    J Med Virol; 2009 Jun; 81(6):1002-8. PubMed ID: 19382267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.